CTRI/2010/091/006071已完成3 期
A phase III, randomized, single blind, multicenter, comparative, prospective clinical trial to assess the efficacy and safety of FDC of Olmesartan +Amlodipine +Hydrochlorothiazide bi-layered tablet verses FDC of Olmesartan +Hydrochlorothiazide tablet in patients for the management of essential hypertension.
Aristo Pharmaceuticals Pvt. Ltd. 23-Off veera desai road, Andheri W Mumbai-4000530 个研究点目标入组 220 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 220
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •patients >18 yrs with mild to moderate uncomplicated essential hypertension, patients with mean sitting systolic BP 140-200 mmHg and mean sitting diastolic BP 90-120 mmHg. patients with written informed consent and should be on single antihypertensive drug, etc.
排除标准
- •Pregnant and lactating women, patients with mean sitting systolic BP >200 mmHg and mean sitting diastolic BP >120 mmHg. suspected secondary hypertension, history of MI, stroke, TIA, other Cv events in last 6 months, patients with uncorrected volume or sodium depletion, etc.
研究者
相似试验
进行中（未招募）
不适用
A Phase III multicenter, single blind, randomized, comparative, add?on clinical trial, in three parallel groups, to evaluate the efficacy and safety of a new therapy with adipose?derived autologous stem cells for the treatment of complex perianal fistulas in patients without inflammatory bowel disease FATT I: Fistula Advanced Therapy Trial (I) - FATT 1Treatment of complex perianal fistulas in patients without inflammatory bowel disease.MedDRA version: 8.1Level: LLTClassification code 10002156Term: Anal fistulaEUCTR2006-003370-95-DECELLERIX, S.L.207
进行中（未招募）
不适用
A Phase III multicenter, single blind, randomized, comparative, add?on clinical trial, in three parallel groups, to evaluate the efficacy and safety of a new therapy with adipose?derived autologous stem cells for the treatment of complex perianal fistulas in patients without inflammatory bowel disease FATT I: Fistula Advanced Therapy Trial (I) - FATT 1Treatment of complex perianal fistulas in patients without inflammatory bowel disease.MedDRA version: 8.1Level: LLTClassification code 10002156Term: Anal fistulaEUCTR2006-003370-95-NLCELLERIX, S.L.207
进行中（未招募）
1 期
A Phase III multicenter, single blind, randomized, comparative, add?on clinical trial, in three parallel groups, to evaluate the efficacy and safety of a new therapy with adipose?derived autologous stem cells for the treatment of complex perianal fistulas in patients without inflammatory bowel disease FATT I: Fistula Advanced Therapy Trial (I)EUCTR2006-003370-95-ESCELLERIX, S.L.207
进行中（未招募）
1 期
Safety and immunogenicity of repeated annual exposure to the aQIV vaccine in children following vaccination in trials V118_05 and V118_05E1Prophylaxis for influenza virusMedDRA version: 18.0Level: PTClassification code 10022000Term: InfluenzaSystem Organ Class: 10021881 - Infections and infestationsEUCTR2015-003008-22-FIovartis Pharma Services AG486
进行中（未招募）
不适用
A phase III, randomized, multicenter, single-blind, placebo controlled study to compare the efficacy and safety of Anagrelide retard” versus placebo in at risk” patients with Essential Thrombocythaemiamale and female at risk patients with Essential ThrombocythaemiaMedDRA version: 12.1Level: LLTClassification code 10015493Term: Essential thrombocythaemiaEUCTR2009-017095-24-HUAOP Orphan Pharmaceuticals AG240